Trend: Biopharma embraces digital cognitive assessments to identify behavioral health biomarkers

By SharpBrains | August 14, 2017

_______ The hunt for behav­ioral health bio­mark­ers is har­ness­ing dig­i­tal health at the research stage (Med­C­i­ty News): “Dig­i­tal health com­pa­nies are going through an inter­est­ing trans­for­ma­tion as research insti­tu­tions real­ize the ben­e­fit of their tech­nol­o­gy to col­lect and man­age data for a host of stud­ies. The bio­phar­ma industry’s embrace of some dig­i­tal health tools to manage…

Read More

E‑Newsletter: Neuroimaging + machine learning can predict, with 96% accuracy, whether high-risk 6‑month-old babies will develop autism spectrum disorder (ASD) by age 2

By SharpBrains | June 27, 2017

_____ Time for Sharp­Brains’ June e‑newsletter, fea­tur­ing fas­ci­nat­ing sci­en­tif­ic find­ings, promis­ing assess­ments, ther­a­pies and brain health mon­i­tor­ing tools…and some fun opti­cal illu­sions :-) New research Study com­bines neu­roimag­ing with machine learn­ing to pre­dict, with 96% accu­ra­cy, whether high-risk 6‑month-old babies will devel­op autism spec­trum dis­or­der (ASD) by age 2 Cog­ni­tive Train­ing or Gingko Bilo­ba to pre­vent cog­ni­tive decline and…

Read More

Digital brain health goes global: Savonix raises $5.1 million to commercialize mobile neurocognitive assessment in the US, China and Japan

By SharpBrains | June 14, 2017

— Savonix gets $5.1M to advance dig­i­tal neu­rocog­ni­tive assess­ment (Mobi­Health News): “San Fran­­cis­­co-based Savonix, mak­er of an app for neu­rocog­ni­tive assess­ment, has raised $5.1 mil­lion in a new round of fund­ing. Dig­iTx Part­ners led the round with addi­tion­al con­tri­bu­tion from ReThink Impact.

Read More